Cargando…
Experimental Models of Multiple Sclerosis
Multiple Sclerosis (MS) is an enigmatic immune mediated disease of the central nervous system that affects about 350,000 individuals in the US, and many more around the world. The mechanism of this disease is largely unknown and there is no cure for it. However, there are several well-characterized...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor Corporativo: | |
| Otros Autores: | , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
New York, NY :
Springer US : Imprint: Springer,
2005.
|
| Edición: | 1st ed. 2005. |
| Temas: | |
| Acceso en línea: | Texto Completo |
MARC
| LEADER | 00000nam a22000005i 4500 | ||
|---|---|---|---|
| 001 | 978-0-387-25518-7 | ||
| 003 | DE-He213 | ||
| 005 | 20220119044501.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 100301s2005 xxu| s |||| 0|eng d | ||
| 020 | |a 9780387255187 |9 978-0-387-25518-7 | ||
| 024 | 7 | |a 10.1007/b135502 |2 doi | |
| 050 | 4 | |a QR180-189.5 | |
| 072 | 7 | |a MJCM |2 bicssc | |
| 072 | 7 | |a MED044000 |2 bisacsh | |
| 072 | 7 | |a MJCM |2 thema | |
| 082 | 0 | 4 | |a 571.96 |2 23 |
| 082 | 0 | 4 | |a 616.079 |2 23 |
| 245 | 1 | 0 | |a Experimental Models of Multiple Sclerosis |h [electronic resource] / |c edited by Ehud Lavi, Cris S. Constantinescu. |
| 250 | |a 1st ed. 2005. | ||
| 264 | 1 | |a New York, NY : |b Springer US : |b Imprint: Springer, |c 2005. | |
| 300 | |a XIV, 902 p. |b online resource. | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 347 | |a text file |b PDF |2 rda | ||
| 505 | 0 | |a Experimental Allergic (Autoimmune) Encephalomyelitis (EAE) -- EAE: History, Clinical Signs, and Disease Course -- Induction of EAE -- Histopathology of EAE -- Neuroantigens in EAE -- Adjuvants in EAE -- The Role of Astrocytes in Autoimmune Disease of the Central Nervous System -- Role of Microglia and Macrophages in Eae -- The Neuron and Axon in Experimental Autoimmune Encephalomyelitis -- Endothelial Cells and Adhesion Molecules in Experimental Autoimmune Encephalomyelitis -- Genetics of Experimental Allergic Encephalomyelitis -- T Lymphocytes in EAE -- The Role of Complement in EAE -- B Cells and Antibodies in Experimental Autoimmune Encephalomyelitis -- Cytokines in Experimental Autoimmune Encephalomyelitis -- The Role of Interferons in Experimental Autoimmune Encephalomyelitis -- The Role of Growth Factors in Experimental Autoimmune Encephalomyelitis -- The Chemokine System in Experimental Autoimmune Encephalomyelitis -- Free Radicals and Experimental Autoimmune Encephalomyelitis -- Proteases and Peptidases in EAE -- The Blood-Brain Barrier in EAE -- Immunomodulation of EAE: Altered Peptide Ligands, Tolerance, and Th1/Th2 -- The Role of Costimulation in Experimental Autoimmune Encephalomyelitis -- Epitope Spreading in EAE -- Apoptotic Cell Death in Experimental Autoimmune Encephalomyelitis -- Environmental Influences in Experimental Autoimmune Encephalomyelitis -- Hormonal and Gender Influences on Experimental Autoimmune Encephalomyelitis -- Experimental Autoimmune Encephalomyelitis in Primates -- Theiler's Murine Encephalomyelitis Virus (TMEV) - Induced Demyelination -- Histopathology in the Theiler's Virus Model of Demyelination -- TMEV and Neuroantigens: Myelin Genes and Proteins, Molecular Mimicry, Epitope Spreading, and Autoantibody-Mediated Remyelination -- The Role of Astrocytes, Oligodendrocytes, Microglia and Endothelial Cells in TMEV Infection -- Immunogenetics, Resistance, and Susceptibility to Theiler's Virus Infection -- The Role of T Cells and the Innate Immune System in the Pathogenesis of Theiler's Virus Demyeliating Disease -- Cytokines, Chemokines and Adhesion Molecules in TMEV-IDD -- Molecular Determinants of TMEV Pathogenesis -- Nitric Oxide in TMEV -- Theiler's Murine Encephalomyelitis Virus (TMEV)-Induced Demyelination -- Corona Virus-Induced Demyelination -- Histopathology in Coronavirus-Induced Demyelination -- The Role of Astrocytes, Microglia, and Endothelial Cells in Coronavirus-Induced Demyelination -- Axons and Neurons in Corona Virus-Induced Demyelination -- The Role of T Cells in Corona-Virus-Induced Demyelination -- The Role of Humoral Immunity in Mouse Hepatitis Virus Induced Demyelination -- The Role of T Cell Epitopes in Coronavirus Infection -- Coronaviruses and Neuroantigens: myelin proteins, myelin genes -- Coronavirus-Induced Demyelination and Spontaneous Remyelination -- Chemokines in Coronavirus-Induced Demyelination -- Coronavirus Receptors -- Apoptosis in MHV-Induced Demyelination -- The Role of Metalloproteinases in Corona Virus Infection -- Molecular Determinants of Coronavirus Mhv- Induced Demyelination -- Demyelination Induced by Other Viruses -- Semliki Forest Virus Induced Demyelination -- The Pathogenesis of Canine Distemper Virus Induced Demyelination. | |
| 520 | |a Multiple Sclerosis (MS) is an enigmatic immune mediated disease of the central nervous system that affects about 350,000 individuals in the US, and many more around the world. The mechanism of this disease is largely unknown and there is no cure for it. However, there are several well-characterized experimental animal models that help us understand and speculate about potential mechanisms of pathology in this disease. Many of the experimental therapies designed for this disease rely on testing the drugs in animal models before using it in clinical trials. This book combines for the first time the different experimental models for MS (including immune-mediated and viral) under one roof, and highlights aspects that are different or shared among these experimental models. It's aim is to improve our understanding of this devastating disease and help us think about potential additional therapies for it. Experimental Models of Multiple Sclerosis will be an important reference for neuroscientists, neurologists, immunologists, microbiologists (especially virologists) and pathologists (especially neuropathologists). Health professionals involved with MS, and medical students will also benefit from this book. | ||
| 650 | 0 | |a Immunology. | |
| 650 | 0 | |a Virology. | |
| 650 | 0 | |a Neurosciences. | |
| 650 | 0 | |a Pathology. | |
| 650 | 0 | |a Neurology . | |
| 650 | 1 | 4 | |a Immunology. |
| 650 | 2 | 4 | |a Virology. |
| 650 | 2 | 4 | |a Neuroscience. |
| 650 | 2 | 4 | |a Pathology. |
| 650 | 2 | 4 | |a Neurology. |
| 700 | 1 | |a Lavi, Ehud. |e editor. |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 700 | 1 | |a Constantinescu, Cris S. |e editor. |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 710 | 2 | |a SpringerLink (Online service) | |
| 773 | 0 | |t Springer Nature eBook | |
| 776 | 0 | 8 | |i Printed edition: |z 9780387506364 |
| 776 | 0 | 8 | |i Printed edition: |z 9780387255170 |
| 856 | 4 | 0 | |u https://doi.uam.elogim.com/10.1007/b135502 |z Texto Completo |
| 912 | |a ZDB-2-SBL | ||
| 912 | |a ZDB-2-SXB | ||
| 950 | |a Biomedical and Life Sciences (SpringerNature-11642) | ||
| 950 | |a Biomedical and Life Sciences (R0) (SpringerNature-43708) | ||